In this work, we observed a notable decrease in TNP2 expression within the SA group, aligning with earlier studies that indicate reduced TNP2 levels in individuals diagnosed with NOA, including SA and Sertoli cell-only syndrome (SCOS) [32,33,43–45]. Here, TNP2 is linked to small cell osteogenic sarcoma.